Enhancing the antitumoral effect of hypericin‐mediated photodynamic therapy by hyperthermia
暂无分享,去创建一个
[1] R. Pedley,et al. Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin a-4 3-O-phosphate. , 2001, Cancer research.
[2] M W Berns,et al. Demonstration of synergistic effects of hyperthermia and photodynamic therapy using the chick chorioallantoic membrane model , 1992, Lasers in surgery and medicine.
[3] K. Sano,et al. The anti-tumor effect of photodynamic therapy evaluated by bromodeoxyuridine immunohistochemistry. , 1998, International journal of oral and maxillofacial surgery.
[4] K Svanberg,et al. Tumour vessel damage resulting from laser-induced hyperthermia alone and in combination with photodynamic therapy. , 1997, Cancer letters.
[5] W. Merlevede,et al. Cytotoxicity and Antiproliferative Effect of Hypericin and Derivatives after Photosensitization , 1998, Photochemistry and photobiology.
[6] T. Roskams,et al. Photodynamic therapy with hypericin induces vascular damage and apoptosis in the RIF‐1 mouse tumor model , 2002, International journal of cancer.
[7] J. Gray,et al. A new mouse tumor model system (RIF-1) for comparison of end-point studies. , 1980, Journal of the National Cancer Institute.
[8] P. D. de Witte,et al. Photodynamic therapy with hypericin in a mouse P388 tumor model: vascular effects determine the efficacy. , 2001, International journal of oncology.
[9] W. Wilson,et al. Scintigraphic imaging of the hypoxia marker (99m)technetium-labeled 2,2'-(1,4-diaminobutane)bis(2-methyl-3-butanone) dioxime (99mTc-labeled HL-91; prognox): noninvasive detection of tumor response to the antivascular agent 5,6-dimethylxanthenone-4-acetic acid. , 2000, Cancer research.
[10] J. Uitto,et al. Hyperthermia potentiates the effects of aluminum phthalocyanine tetrasulfonate‐mediated photodynamic toxicity in human malignant and normal cell lines , 1991, Lasers in surgery and medicine.
[11] B W Henderson,et al. Interaction of photodynamic therapy and hyperthermia: tumor response and cell survival studies after treatment of mice in vivo. , 1985, Cancer research.
[12] Yan Xu,et al. Efficacy of antitumoral photodynamic therapy with hypericin: Relationship between biodistribution and photodynamic effects in the RIF‐1 mouse tumor model , 2001, International journal of cancer.
[13] C. M. Allen,et al. Photodynamic therapeutics: basic principles and clinical applications. , 1999, Drug discovery today.
[14] D. Meruelo,et al. The chemical and biological properties of hypericin—a compound with a broad spectrum of biological activities , 1995, Medicinal research reviews.
[15] B Chen,et al. Synergistic effect of photodynamic therapy with hypericin in combination with hyperthermia on loss of clonogenicity of RIF-1 cells. , 2001, International journal of oncology.
[16] T. Mang,et al. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. , 1985, Cancer research.
[17] T. Dubbelman,et al. Potentiation of thermal inactivation of glyceraldehyde-3-phosphate dehydrogenase by photodynamic treatment. A possible model for the synergistic interaction between photodynamic therapy and hyperthermia. , 1991, The Biochemical journal.
[18] T. Dubbelman,et al. Synergistic Interaction of Photodynamic Treatment with the Sensitizer Aluminum Phthalocyanine and Hyperthermia on Loss of Clonogenicity of CHO Cells , 1996, Photochemistry and photobiology.
[19] T J Dougherty,et al. TIME and SEQUENCE DEPENDENT INFLUENCE OF IN VITRO PHOTODYNAMIC THERAPY (PDT) SURVIVAL BY HYPERTHERMIA , 1985, Photochemistry and photobiology.
[20] J. J. Schuitmaker,et al. Mechanisms for optimising photodynamic therapy: second-generation photosensitisers in combination with mitomycin C. , 1995, British Journal of Cancer.